Persistence of Virus Reservoirs in ART-Treated SHIV-Infected Rhesus Macaques after Autologous Hematopoietic Stem Cell Transplant

PLoS Pathogens

Volumn 10, Issue 9, 2014, Pages

  Mavigner, Maud ^a   Watkins, Benjamin ^b   Lawson, Benton ^a   Lee, S Thera ^a   Chahroudi, Ann ^a,b,c   Kean, Leslie ^b   Silvestri, Guido ^a,b  

^a EMORY UNIVERSITY   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CIDOFOVIR; EFAVIRENZ; EMTRICITABINE; ENROFLOXACIN; FLUCONAZOLE; NEOMYCIN; POLYMYXIN B; RALTEGRAVIR; TENOFOVIR; VALGANCICLOVIR; VIRUS DNA; VIRUS RNA; RNA DIRECTED DNA POLYMERASE;

ANIMAL EXPERIMENT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ENGRAFTMENT; FLOW CYTOMETRY; IMMUNOPHENOTYPING; LYMPH NODE; MALE; MYELOABLATIVE CONDITIONING; NEUTROPHIL COUNT; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN HUMAN IMMUNODEFICIENCY VIRUS INFECTION; SPLEEN; VIREMIA; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; WHOLE BODY RADIATION; ADVERSE EFFECTS; ANIMAL; AUTOTRANSPLANTATION; DRUG EFFECTS; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; MONONUCLEAR CELL; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY; VIRUS LATENCY;

MACACA MULATTA; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

ANIMALS; ANTI-RETROVIRAL AGENTS; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV REVERSE TRANSCRIPTASE; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; MALE; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSPLANTATION, AUTOLOGOUS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84907572532     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004406     Document Type: Article

References (23)

1. Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, et al. (1997) Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A 94: 13193–13197.
2. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, et al. (1997) Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278: 1295–1300.
3. Chun TW, Justement JS, Murray D, Hallahan CW, Maenza J, et al. (2010) Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication. AIDS 24: 2803–2808.
4. Davey RT, JrBhat N, Yoder C, Chun TW, Metcalf JA, et al. (1999) HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci U S A 96: 15109–15114.
5. Hutter G, Nowak D, Mossner M, Ganepola S, Mussig A, et al. (2009) Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 360: 692–698.
6. Allers K, Hutter G, Hofmann J, Loddenkemper C, Rieger K, et al. (2011) Evidence for the cure of HIV infection by CCR5Delta32/Delta32 stem cell transplantation. Blood 117: 2791–2799.
7. Yukl SA, Boritz E, Busch M, Bentsen C, Chun TW, et al. (2013) Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient. PLoS Pathog 9: e1003347.
8. Henrich TJ, Hu Z, Li JZ, Sciaranghella G, Busch MP, et al. (2013) Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. J Infect Dis 207: 1694–1702.
9. Henrich TJ, Hanhauser E, Sirigano M, Davis B, Lee T-H, et al. (IAS 2013) In depth investigation of peripheral and gut HIV-1 reservoirs, HIV-specific cellular immunity, and host microchimerism following allogeneic hematopoetic stem cell transplantation. IAS 2013. Kuala Lumpur, Malaysia.
10. Evans DT, Silvestri G, (2013) Nonhuman primate models in AIDS research. Curr Opin HIV AIDS 8: 255–261.
11. Dinoso JB, Rabi SA, Blankson JN, Gama L, Mankowski JL, et al. (2009) A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy. J Virol 83: 9247–9257.
12. Kearney M, Spindler J, Shao W, Maldarelli F, Palmer S, et al. (2011) Genetic diversity of simian immunodeficiency virus encoding HIV-1 reverse transcriptase persists in macaques despite antiretroviral therapy. J Virol 85: 1067–1076.
13. North TW, Higgins J, Deere JD, Hayes TL, Villalobos A, et al. (2010) Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS. J Virol 84: 2913–2922.
14. Shytaj IL, Norelli S, Chirullo B, Della Corte A, Collins M, et al. (2012) A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model. PLoS Pathog 8: e1002774.
15. Malphettes M, Carcelain G, Saint-Mezard P, Leblond V, Altes HK, et al. (2003) Evidence for naive T-cell repopulation despite thymus irradiation after autologous transplantation in adults with multiple myeloma: role of ex vivo CD34+ selection and age. Blood 101: 1891–1897.
16. Henrich TJ, Hanhauser E, Sirigano M, Li JZ, Lichterfeld M, et al. (2014) HIV-1 Rebound Following Allogeneic Stem Cell Transplantation and Treatment Interruption. CROI 2014. Boston.
17. Larsen CP, Page A, Linzie KH, Russell M, Deane T, et al. (2010) An MHC-defined primate model reveals significant rejection of bone marrow after mixed chimerism induction despite full MHC matching. Am J Transplant 10: 2396–2409.
18. Kean LS, Adams AB, Strobert E, Hendrix R, Gangappa S, et al. (2007) Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression. Am J Transplant 7: 320–335.
19. Hofman MJ, Higgins J, Matthews TB, Pedersen NC, Tan C, et al. (2004) Efavirenz therapy in rhesus macaques infected with a chimera of simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1. Antimicrob Agents Chemother 48: 3483–3490.
20. North TW, Van Rompay KK, Higgins J, Matthews TB, Wadford DA, et al. (2005) Suppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1. J Virol 79: 7349–7354.
21. Soderberg K, Denekamp L, Nikiforow S, Sautter K, Desrosiers RC, et al. (2002) A nucleotide substitution in the tRNA(Lys) primer binding site dramatically increases replication of recombinant simian immunodeficiency virus containing a human immunodeficiency virus type 1 reverse transcriptase. J Virol 76: 5803–5806.
22. Miller WP, Srinivasan S, Panoskaltsis-Mortari A, Singh K, Sen S, et al. (2010) GVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28− CD8+ T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppression. Blood 116: 5403–5418.
23. Silvestri G, Sodora DL, Koup RA, Paiardini M, O'Neil SP, et al. (2003) Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18: 441–452.